Donald Debethizy Insider Profile
4 Followers
Donald Debethizy, President & CEO, Director at Gyre Therapeutics, holds 798.00 shares in Gyre Therapeutics (Ticker: GYRE). Most recently, Donald Debethizy Bought 798 shares of Gyre Therapeutics on Feb 16, 2012 for an estimated value of $4.07K.
Donald Debethizy's Trading History
| GYREGyre Therapeutics | Feb 16, 2012 | President & CEO, Director | Informative Buy | 4.07K | $3.50K | |
GYRE Insider Shares: 798.00 (<0.01%) | ||||||
You May Also Like
Donald Debethizy insider profile FAQ
What is the percentage of profitable transactions made by Donald Debethizy?
The percentage of profitable transactions made by Donald Debethizy is 0%.
What is the average return per transaction made by Donald Debethizy?
The average return per transaction made by Donald Debethizy is -22.30%.
What stocks does Donald Debethizy hold?
Donald Debethizy holds: GYRE stocks.
What was Donald Debethizy’s latest transaction?
Donald Debethizy’s latest transaction was an Informative Buy of $4.07K.
What was Donald Debethizy's most profitable transaction?
Donald Debethizy’s most profitable transaction was an Informative Sell of GYRE stock on December 18, 2009. The return on the trade was -15.70%.
What is Donald Debethizy's role in Gyre Therapeutics?
Donald Debethizy's role in Gyre Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
